{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T21:32:00Z","timestamp":1781818320949,"version":"3.54.5"},"reference-count":24,"publisher":"SAGE Publications","issue":"6","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Transgender Health"],"published-print":{"date-parts":[[2025,12]]},"abstract":"<jats:sec>\n                    <jats:title>Purpose:<\/jats:title>\n                    <jats:p>We explored the relationship between body composition parameters and achieved hormone levels in transgender\/gender diverse (TGD) adolescents on gender-affirming hormones.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>This retrospective study was conducted between January 2018 and January 2023 and included 159 TGD adolescents (109 TGD males) aged \u226421 years and treated with gender-affirming hormones. Body composition was assessed by bioelectrical impedance analysis. Anthropometric measurements, treatment dose, and hormone levels were extracted from medical files. The outcome measures were estradiol and testosterone levels in correlation with indices of adiposity and muscle adjusted for treatment dose and duration.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>\n                      Peak testosterone blood levels, adjusted for dose and treatment duration, correlated negatively with body mass index z-score (\n                      <jats:italic toggle=\"yes\">r<\/jats:italic>\n                      = \u22120.541,\n                      <jats:italic toggle=\"yes\">p<\/jats:italic>\n                      &lt; 0.001), fat mass (\n                      <jats:italic toggle=\"yes\">r<\/jats:italic>\n                      = \u22120.454,\n                      <jats:italic toggle=\"yes\">p<\/jats:italic>\n                      = 0.004), truncal fat mass (\n                      <jats:italic toggle=\"yes\">r<\/jats:italic>\n                      = \u22120.444,\n                      <jats:italic toggle=\"yes\">p<\/jats:italic>\n                      = 0.005), appendicular skeletal muscle mass (\n                      <jats:italic toggle=\"yes\">r<\/jats:italic>\n                      = \u22120.660,\n                      <jats:italic toggle=\"yes\">p<\/jats:italic>\n                      &lt; 0.001), skeletal muscle mass index (\n                      <jats:italic toggle=\"yes\">r<\/jats:italic>\n                      = \u22120.566,\n                      <jats:italic toggle=\"yes\">p<\/jats:italic>\n                      &lt; 0.001), body surface area (BSA;\n                      <jats:italic toggle=\"yes\">r<\/jats:italic>\n                      = \u22120.620,\n                      <jats:italic toggle=\"yes\">p<\/jats:italic>\n                      &lt; 0.001), and estimated basal metabolic rate (\n                      <jats:italic toggle=\"yes\">r<\/jats:italic>\n                      = \u22120.658,\n                      <jats:italic toggle=\"yes\">p<\/jats:italic>\n                      &lt; 0.001). Trough testosterone blood levels, adjusted for dose and treatment duration, correlated but to a lesser extent with muscle indices and BSA. Estradiol levels in TGD females did not correlate significantly with body composition parameters.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>Our results demonstrate an association between both adipose and muscle mass and testosterone levels. This is of special importance, as TGD youth exhibit a higher frequency of differing weight status and body composition. These findings enable a more individualized approach to medication dosing for TGD adolescents. Body surface area may be a potential indicator for determining the appropriate testosterone dose in cases where data on body composition are unavailable.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1089\/trgh.2022.0218","type":"journal-article","created":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T12:39:05Z","timestamp":1719837545000},"page":"510-516","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":1,"title":["The Role of Body Composition Assessment in Tailoring Gender-Affirming Treatment for Transgender\/Gender Diverse Youth"],"prefix":"10.1177","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8207-1130","authenticated-orcid":false,"given":"Liat","family":"Perl","sequence":"first","affiliation":[{"name":"The Institute of Pediatric Endocrinology, Diabetes and Metabolism, Dana-Dwek Children\u2019s Hospital, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel."},{"name":"Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Avivit","family":"Brener","sequence":"additional","affiliation":[{"name":"The Institute of Pediatric Endocrinology, Diabetes and Metabolism, Dana-Dwek Children\u2019s Hospital, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel."},{"name":"Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ophir","family":"Borger","sequence":"additional","affiliation":[{"name":"The Institute of Pediatric Endocrinology, Diabetes and Metabolism, Dana-Dwek Children\u2019s Hospital, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel."},{"name":"Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel."},{"name":"The Nutrition &amp; Dietetics Unit, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anat","family":"Segev-Becker","sequence":"additional","affiliation":[{"name":"The Institute of Pediatric Endocrinology, Diabetes and Metabolism, Dana-Dwek Children\u2019s Hospital, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel."},{"name":"Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Galit","family":"Israeli","sequence":"additional","affiliation":[{"name":"The Institute of Pediatric Endocrinology, Diabetes and Metabolism, Dana-Dwek Children\u2019s Hospital, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yael","family":"Lebenthal","sequence":"additional","affiliation":[{"name":"The Institute of Pediatric Endocrinology, Diabetes and Metabolism, Dana-Dwek Children\u2019s Hospital, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel."},{"name":"Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2790-8866","authenticated-orcid":false,"given":"Asaf","family":"Oren","sequence":"additional","affiliation":[{"name":"The Institute of Pediatric Endocrinology, Diabetes and Metabolism, Dana-Dwek Children\u2019s Hospital, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel."},{"name":"Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2026,1,21]]},"reference":[{"key":"e_1_3_3_2_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41574-021-00535-9"},{"key":"e_1_3_3_3_2","doi-asserted-by":"publisher","DOI":"10.4158\/EP-2019-0418"},{"key":"e_1_3_3_4_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00431-020-03906-y"},{"key":"e_1_3_3_5_2","volume-title":"How many adults and youth identify as transgender in the United States? Executive summary","author":"Herman JL","year":"2022","unstructured":"Herman JL, , Flores AR, , O\u2019neill KK. How many adults and youth identify as transgender in the United States? Executive summary. The Williams Institute, UCLA School of Law, LA, CA, USA. 2022."},{"key":"e_1_3_3_6_2","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2017-01658"},{"key":"e_1_3_3_7_2","doi-asserted-by":"publisher","DOI":"10.1089\/lgbt.2018.0116"},{"key":"e_1_3_3_8_2","doi-asserted-by":"publisher","DOI":"10.1177\/2042018820924543"},{"key":"e_1_3_3_9_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.eprac.2020.10.013"},{"key":"e_1_3_3_10_2","doi-asserted-by":"publisher","DOI":"10.1089\/chi.2021.0155"},{"key":"e_1_3_3_11_2","doi-asserted-by":"publisher","DOI":"10.1007\/s40618-023-02156-7"},{"key":"e_1_3_3_12_2","doi-asserted-by":"publisher","DOI":"10.1080\/15532739.2011.700873"},{"issue":"246","key":"e_1_3_3_13_2","first-page":"1","article-title":"2000 CDC growth charts for the United States: Methods and development","author":"Kuczmarski RJ","year":"2002","unstructured":"Kuczmarski RJ, , Ogden CL, , Guo SS, et al. 2000 CDC growth charts for the United States: Methods and development. Vital Health Stat 11, 2002;(246):1\u2013190.","journal-title":"Vital Health Stat 11"},{"issue":"25","key":"e_1_3_3_14_2","first-page":"1","article-title":"Changes in terminology for childhood overweight and obesity","author":"Ogden CL","year":"2010","unstructured":"Ogden CL, , Flegal KM. Changes in terminology for childhood overweight and obesity. Natl Health Stat Report, 2010;(25):1\u20135.","journal-title":"Natl Health Stat Report"},{"key":"e_1_3_3_15_2","doi-asserted-by":"publisher","DOI":"10.1097\/MCO.0b013e32830b5f23"},{"key":"e_1_3_3_16_2","doi-asserted-by":"publisher","DOI":"10.1097\/MPG.0000000000002068"},{"key":"e_1_3_3_17_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.2047-6310.2013.00168.x"},{"key":"e_1_3_3_18_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2265.2008.03251.x"},{"key":"e_1_3_3_19_2","doi-asserted-by":"publisher","DOI":"10.1186\/s12887-021-02695-z"},{"key":"e_1_3_3_20_2","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2006-0822"},{"key":"e_1_3_3_21_2","doi-asserted-by":"publisher","DOI":"10.1016\/0022-4731(83)90225-X"},{"key":"e_1_3_3_22_2","doi-asserted-by":"publisher","DOI":"10.1055\/s-0043-107835"},{"key":"e_1_3_3_23_2","doi-asserted-by":"publisher","DOI":"10.1089\/trgh.2017.0035"},{"key":"e_1_3_3_24_2","doi-asserted-by":"publisher","DOI":"10.1002\/j.1552-4604.1995.tb04143.x"},{"key":"e_1_3_3_25_2","doi-asserted-by":"publisher","DOI":"10.1158\/1055-9965.EPI-03-0026"}],"container-title":["Transgender Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1089\/trgh.2022.0218","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1089\/trgh.2022.0218","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1089\/trgh.2022.0218","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T22:41:51Z","timestamp":1777588911000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1089\/trgh.2022.0218"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":24,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["10.1089\/trgh.2022.0218"],"URL":"https:\/\/doi.org\/10.1089\/trgh.2022.0218","relation":{},"ISSN":["2688-4887","2380-193X"],"issn-type":[{"value":"2688-4887","type":"print"},{"value":"2380-193X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12]]}}}